http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102234287-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5365 |
| filingDate | 2010-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102234287-B |
| titleOfInvention | Nitro glyoxaline compound, Preparation Method And The Use |
| abstract | The present invention relates to nitro glyoxaline compound, Preparation Method And The Use.Particularly, the invention provides the novel nitro glyoxaline compound of a class, and the purposes in pharmacy acceptable salt, preparation method and its medicine of infectious diseases caused preparation treatment tuberculosis bacillus infectious disease, particularly multidrug resistance tubercule bacillus.Nitro glyoxaline compound of the present invention or its pharmacy acceptable salt, have good In Vitro Anti tubercule bacillus active, particularly have very strong activity to resistance tubercule bacillus. |
| priorityDate | 2010-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 149.